| Uniprot ID: | O00206 |
| Secondary ID: | A8K1Y8 |
| Symbol: | TLR4 |
| Other Name: | hToll, |
| Class: | Single Protein |
| Type: | pro-fibrotic |
| Molecular Function: | Receptor |
| Category I | Category II | Category III |
|---|---|---|
| Extracellular | Toll-like receptor |
Reference Record 1
| PubMed ID | 28634394 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice | Fibrosis Disease | Biliary fibrosis |
| Process I | |||
| Process II | HSCs activation | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 2
| PubMed ID | 27722989 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Peritoneal fibrosis |
| Process I | regulate cytokines and growth factors | ||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting TLR4/MyD88/ NF-κB signaling | ||
Reference Record 3
Reference Record 4
| PubMed ID | 25552658 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice | Fibrosis Disease | Muscle fibrosis |
| Process I | attenue inflammation,macrophage polarization | ||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 5
| PubMed ID | 24842252 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice | Fibrosis Disease | Renal fibrosis |
| Process I | attenue inflammation | ||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 6
| PubMed ID | 20595685 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice | Fibrosis Disease | Renal fibrosis |
| Process I | |||
| Process II | cells proliferation | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting TGF-β signaling | ||
Reference Record 7
| PubMed ID | 18694726 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Liver fibrosis |
| Process I | attenue inflammation | ||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 8
| PubMed ID | 18007026 | Compound ID | |
| CAS | Name | ||
| Model | mice | Fibrosis Disease | Cardiac fibrosis |
| Process I | attenue inflammation | ||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 9
| PubMed ID | 17952090 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice | Fibrosis Disease | Liver fibrosis |
| Process I | attenue inflammation | ||
| Process II | HSCs activation | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting LR4-Bambi–TGF-β signaling | ||
Reference Record 10
| PubMed ID | 29379592 | Compound ID | |
| CAS | Name | ||
| Model | human | Fibrosis Disease | Liver fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 11